Leptin gene therapy in the fight against diabetes

Yuqing Wang, Akihiro Asakawa, Akio Inui, Ken Ichiro Kosai

研究成果: ジャーナルへの寄稿総説査読

5 被引用数 (Scopus)

抄録

Importance of the field: The incidence of diabetes is increasing worldwide, yet current treatments are not always effective for all patient or disease types. Areas covered in this review: Here, we summarize the biologic and clinical roles of leptin in diabetes, and discuss candidate viral vectors that may be employed in the clinical use of central leptin gene therapy for diabetes. What the reader will gain: We discuss how studies on leptin, a regulator of the insulinglucose axis, have significantly advanced our understanding of the roles of energy homeostasis and insulin resistance in the pathogeneses of metabolic syndrome and diabetes. Recent studies have demonstrated the long-term therapeutic effects of central leptin gene therapy in obesity and diabetes via decreased insulin resistance and increased glucose metabolism. Many of these studies have employed viral vectors, which afford high in vivo gene transduction efficiencies compared with non-viral vectors. Take home message: Adeno-associated viral vectors are particularly well suited for central leptin gene therapy owing to their low toxicity and ability to drive transgene expression for extended periods.

本文言語英語
ページ(範囲)1405-1414
ページ数10
ジャーナルExpert Opinion on Biological Therapy
10
10
DOI
出版ステータス出版済み - 10月 2010
外部発表はい

!!!All Science Journal Classification (ASJC) codes

  • 薬理学
  • 創薬
  • 臨床生化学

フィンガープリント

「Leptin gene therapy in the fight against diabetes」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル